Oral Corticosteroid Dosing for a 10-kg Child
For a 10-kg child requiring oral corticosteroids for inflammatory or immunosuppressive therapy, use 1-2 mg/kg/day of prednisone or prednisolone (10-20 mg/day for this child), with the specific dose depending on the indication and severity. 1
Indication-Specific Dosing
For Acute Asthma Exacerbations
- Dose: 1-2 mg/kg/day (10-20 mg/day for a 10-kg child), maximum 60 mg/day
- Duration: 3-10 days
- Can be given as a single daily dose or divided into 2 doses 1
- No tapering needed for courses ≤10 days 1
The evidence strongly supports that 1 mg/kg/day is as effective as 2 mg/kg/day for acute moderate asthma exacerbations. A 2021 randomized trial demonstrated non-inferiority of the lower dose with significantly less vomiting (relative risk 0.19-0.99) 2. Additionally, a 2002 study showed that 2 mg/kg/day caused twice the rate of behavioral side effects—particularly anxiety and aggressive behavior—without additional clinical benefit 3. For this 10-kg child with asthma, start with 10 mg/day (1 mg/kg) rather than 20 mg/day.
For Nephrotic Syndrome or Other Immunosuppressive Therapy
- Preferred dosing: 60 mg/m² BSA/day (standard guideline recommendation)
- Weight-based alternative: 2 mg/kg/day (20 mg/day for a 10-kg child)
Critical caveat: Weight-based dosing (2 mg/kg) significantly underdoses children <30 kg compared to BSA-based dosing. For a 10-kg child, the weight-based dose delivers only 85% of the BSA-based dose on average 4. This discrepancy is clinically meaningful—30% of children in one study received >5 mg/day less than recommended when using weight-based dosing 4.
Practical solution for this 10-kg child: Use the simplified equation [2 × weight + 8] to approximate 60 mg/m² dosing = [2 × 10 + 8] = 28 mg/day 5. This equation has been validated with an average error of only 3.4% and avoids the need to measure height or calculate BSA 5.
Key Clinical Considerations
Dosing Method Selection
- For acute inflammatory conditions (asthma, croup): Weight-based dosing (1-2 mg/kg) is appropriate and guideline-endorsed 1
- For chronic immunosuppressive therapy (nephrotic syndrome, autoimmune conditions): BSA-based dosing (60 mg/m²) is superior to prevent underdosing in young children 4
Administration
- Single daily morning dose minimizes HPA axis suppression
- Can divide into twice-daily dosing for better GI tolerance if needed 1
- Oral absorption is reliable; IV offers no advantage unless GI dysfunction present 1
Duration and Tapering
- Short courses (3-10 days): No taper required, especially if concurrent inhaled corticosteroids 1
- Longer courses: Taper may be needed to prevent adrenal insufficiency
Monitoring for Adverse Effects
Common issues in children include:
- Behavioral changes (anxiety, aggression, hyperactivity)—more frequent at 2 mg/kg vs 1 mg/kg 3
- Vomiting—significantly reduced with 1 mg/kg dosing 2
- Hyperglycemia
- Growth suppression with prolonged use
- Immunosuppression
Alternative: Dexamethasone
For acute asthma, single-dose oral dexamethasone 0.6 mg/kg (6 mg for a 10-kg child, maximum 18 mg) is equally effective as 5 days of prednisolone and may improve compliance 6. This eliminates the need for multi-day dosing but is not appropriate for chronic immunosuppressive therapy.